Banyan Partners’s Novo Nordisk NVO Stock Holding History

Banyan Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-47,856	Closed	-$1.09M	–	393
2014 Q1	$1.09M	Buy	+47,856	New	+$1.02M	0.09%	216
2013 Q4	–	Sell	-12,390	Closed	-$210K	–	432
2013 Q3	$210K	Buy	+12,390	New	+$208K	0.02%	320

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Banyan Partners's NVO Position: Q2 2014 in Review

Banyan Partners sold out of Novo Nordisk (NVO) in Q2 2014, closing a stake of 47,856 shares — an estimated $1.09M sold.

Banyan Partners first reported a position in NVO in Q3 2013 and held it in 2 quarters. The position peaked at $1.09M in Q1 2014. 473 funds tracked by Wall St. Rank hold NVO as of Q2 2014.

Banyan Partners reported no remaining Novo Nordisk position as of Q2 2014 after selling out during the quarter.
Banyan Partners sold 47,856 Novo Nordisk shares in Q2 2014, an estimated $1.09M.
Banyan Partners first reported a position in Novo Nordisk in Q3 2013 and held it in 2 quarters.
Banyan Partners's Novo Nordisk position peaked at $1.09M in Q1 2014.
473 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2014.

Based on Banyan Partners's 13F filing for Q2 2014, filed 8 Aug 2014.